Health Industry

Latest California Healthline Stories

California Bans Controversial ‘Excited Delirium’ Diagnosis

California is the first state to ban the controversial diagnosis known as “excited delirium,” which has been used increasingly to justify excessive force by law enforcement. A human rights advocate described the law, signed this week by Gov. Gavin Newsom, as a “watershed moment” in criminal justice.

‘I’m So Burned Out’: Fighting to See a Specialist Amplified Pain for Riverside County Woman

Teresa Johnson has been in extreme pain for more than a year after what she believes was a severe allergic reaction to iodine. Her Medi-Cal plan approved her referral to a specialist, but it took her numerous phone calls, multiple complaints, and several months to book an appointment.

Trump Misplaced Blame When He Said Drug Shortages Were Biden’s Fault

Former President Donald Trump, who’s running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don’t align with Trump’s claims; by some measures, drug shortages increased more on Trump’s watch than on Biden’s.

Mothers of Color Can’t See if Providers Have a History of Mistreatment. Why Not?

Many women, especially Black women, have reported discrimination in maternity care, but expectant mothers lack tools to see where this happens. Funding and regulations to measure disparities have been slow in arriving, but some innovators are trying to fill the void.

What Mobile Clinics in Dollar General Parking Lots Say About Health Care in Rural America

Dollar General’s pilot mobile clinic program has been touted by company officials, rural health experts, and analysts as a model that could help solve rural America’s primary care shortage. But its Tennessee launch has been met with local skepticism.

Who Polices Hospitals Merging Across Markets? States Give Different Answers

Increasingly, hospitals are merging across separate markets within states. It’s a move that health economists and the Federal Trade Commission have been closely watching, as evidence shows such mergers raise prices for patients with no improvement in care.